Ventas, Inc. (VTR) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Ventas, Inc. (VTR) Real Estate Portfolio & Strategy

Ventas, Inc. (VTR) is a leading S&P 500 REIT investing in healthcare and senior living properties. Ventas partners with healthcare providers and research institutions, leveraging demographic trends to drive consistent cash flow and shareholder returns. The company's diversified portfolio and experienced management team position it as a key player in the healthcare real estate sector.

What Is the Investment Thesis for VTR?

Ventas, Inc. presents a notable research candidate within the healthcare REIT sector. The company's diversified portfolio of healthcare properties, including senior housing, medical office buildings, and life science facilities, positions it to benefit from the aging population and increasing demand for healthcare services. Ventas' focus on partnering with leading care providers and research institutions enhances its competitive advantage. With a dividend yield of 2.26% and a beta of 0.77, Ventas offers a blend of income and relative stability. The company's P/E ratio of 163.7 suggests a premium valuation, reflecting investor confidence in its long-term growth prospects. Key catalysts include strategic acquisitions and development projects that expand its portfolio and enhance its revenue streams. However, investors should be aware of potential risks, such as interest rate fluctuations and regulatory changes in the healthcare industry.

Based on FMP financials and quantitative analysis

VTR Key Highlights

Market capitalization of $44.7B, reflecting its significant presence in the REIT sector.

• P/E ratio of 163.7, indicating investor expectations for future growth.
• Dividend yield of 2.26%, providing a steady income stream for investors.
• Beta of 0.77, suggesting lower volatility compared to the overall market.
• Operates approximately 1,200 properties as of September 30, 2020, showcasing its extensive portfolio.

Who Are VTR's Competitors?

VTR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VTR's Key Strengths?

Diversified portfolio of healthcare properties

• Strategic partnerships with leading care providers and research institutions
• Experienced management team
• Strong balance sheet

What Are VTR's Weaknesses?

Exposure to interest rate fluctuations

• Dependence on the healthcare industry
• High P/E ratio
• Gross Margin is negative

What Could Drive VTR Stock Higher?

Strategic acquisitions of healthcare properties to expand the portfolio.

• Development projects to create new senior housing communities and medical office buildings.
• Integration of technology solutions to enhance the tenant experience and improve operational efficiency.
• Demographic trends driving increased demand for healthcare services.

What Are the Key Risks for VTR?

Financial-distress signal — its Altman Z-Score of 1.79 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.
• Rich valuation — a P/E of 163.7 runs well above the Real Estate sector’s ~21x, leaving little room for a miss.
• Regulatory changes in the healthcare industry could impact revenue and profitability.
• Rising interest rates could increase borrowing costs and reduce investment returns.
• Economic downturn could reduce demand for healthcare services and impact occupancy rates.
• Competition from other REITs and healthcare providers could put pressure on rental rates and occupancy rates.
• Fluctuations in property values could impact the company's net asset value.

What Are the Growth Opportunities for VTR?

• Growth opportunity 1: Expansion of Life Science Portfolio: Ventas has the opportunity to expand its life science real estate portfolio, capitalizing on the growing demand for research and development facilities. The global life science tools market is projected to reach $170 billion by 2028, presenting a significant growth opportunity for Ventas. By investing in state-of-the-art facilities and partnering with leading research institutions, Ventas can attract high-quality tenants and generate long-term revenue growth. This strategy aligns with the increasing focus on innovation and drug development in the healthcare industry.
• Growth opportunity 2: Strategic Acquisitions: Ventas can pursue strategic acquisitions of healthcare properties to expand its portfolio and diversify its revenue streams. The REIT market is fragmented, offering opportunities to acquire undervalued assets with growth potential. By carefully selecting acquisitions that align with its investment criteria, Ventas can enhance its market position and improve its financial performance. This strategy requires thorough due diligence and effective integration to ensure successful outcomes. Ventas can target specific geographic markets or property types to optimize its portfolio mix.
• Growth opportunity 3: Development Projects: Ventas can undertake development projects to create new healthcare facilities that meet the evolving needs of its tenants and customers. This includes building new senior housing communities, medical office buildings, and life science facilities. By developing properties from the ground up, Ventas can customize the design and features to attract high-quality tenants and generate higher returns. This strategy requires careful planning, execution, and risk management to ensure successful project completion. Ventas can leverage its expertise in real estate development to create value for its shareholders.
• Growth opportunity 4: International Expansion: Ventas can explore opportunities to expand its operations internationally, capitalizing on the growing demand for healthcare services in other countries. This includes investing in healthcare properties in developed and emerging markets. By diversifying its geographic footprint, Ventas can reduce its exposure to regional economic and regulatory risks. This strategy requires careful consideration of local market conditions, cultural differences, and regulatory requirements. Ventas can partner with local experts to navigate the complexities of international expansion.
• Growth opportunity 5: Technology Integration: Ventas can integrate technology solutions into its properties to enhance the tenant experience and improve operational efficiency. This includes implementing smart building technologies, telehealth platforms, and data analytics tools. By leveraging technology, Ventas can attract tech-savvy tenants and optimize its property management processes. This strategy requires investment in technology infrastructure and training for employees. Ventas can partner with technology providers to develop innovative solutions that meet the specific needs of its tenants and customers.

What Are VTR's Competitive Advantages?

• Diversified portfolio of healthcare properties
• Strategic partnerships with leading care providers and research institutions
• Experienced management team with a proven track record
• Strong balance sheet and access to capital

What Does VTR Do?

Ventas, Inc. operates at the intersection of the healthcare and real estate industries. Founded over twenty years ago, the company has grown into one of the world's foremost Real Estate Investment Trusts (REITs). Ventas strategically employs capital to unlock the value of real estate, forging partnerships with leading care providers, developers, research and medical institutions, innovators, and healthcare organizations. Ventas' success is driven by the demographic tailwind of an aging population, which increases the demand for healthcare and senior living facilities. Ventas owns or manages approximately 1,200 properties through unconsolidated joint ventures. The company's portfolio includes senior housing communities, medical office buildings, and life science facilities. Ventas focuses on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. Ventas' strategy combines a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team.

What Products and Services Does VTR Offer?

• Owns and manages a diversified portfolio of healthcare properties.
• Invests in senior housing communities, medical office buildings, and life science facilities.
• Partners with leading care providers, developers, and research institutions.
• Provides capital to unlock the value of real estate in the healthcare sector.
• Manages approximately 1,200 properties through unconsolidated joint ventures.
• Focuses on producing consistent growing cash flows and superior returns.

How Does VTR Make Money?

• Generates revenue through rental income from its healthcare properties.
• Acquires and develops healthcare properties to expand its portfolio.
• Manages its properties to optimize occupancy rates and rental rates.
• Finances its operations through a combination of debt and equity.

What Industry Does VTR Operate In?

Ventas, Inc. operates within the REIT - Healthcare Facilities industry, which is driven by the increasing demand for healthcare services due to the aging population. The industry is characterized by long-term leases and stable cash flows. Ventas competes with other REITs, healthcare providers, and real estate developers. The market is influenced by factors such as interest rates, regulatory changes, and demographic trends. Ventas' diversified portfolio and strategic partnerships position it as a key player in this competitive landscape. The healthcare REIT sector is expected to continue growing, driven by the increasing demand for senior housing, medical office buildings, and life science facilities.

Who Are VTR's Key Customers?

• Senior housing operators
• Medical office tenants
• Life science companies
• Healthcare providers

Company Profile

Ventas, Inc. operates in the REIT - Healthcare Facilities industry within the Real Estate sector. It is headquartered in Chicago, US. The company is led by CEO Debra A. Cafaro. VTR has traded publicly since 1997.

Ventas, Inc. Financial Trajectory

Ventas, Inc. (VTR) reported $1.73B in revenue for Q2 2026, reflecting 4.4% growth compared to the prior quarter. The company recorded net income of $74.1M, with diluted EPS of $0.14. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Real Estate company. Across the four most recent quarters, VTR averaged $0.14 in diluted EPS.

How Ventas, Inc. Is Valued

Ventas, Inc. carries a market capitalization of $44.7B, placing it in the large-cap category. Relative to its peer group, VTR's quantitative score of 57/100 is roughly in line with the peer average of 66/100.

Return on equity for Ventas, Inc. stands at 2.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. VTR trades at a trailing price-to-earnings ratio of 163.73, above the Real Estate sector average of ~21x. Its free cash flow yield is 3.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.27 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.6%, the inverse of the P/E and a quick read on earnings relative to price.

Ventas, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.79 places it in the distress zone, a signal of elevated financial risk.

Ventas, Inc. has missed Wall Street's EPS estimate in 4 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 3.2% above estimates on average.

Wall Street analysts project Ventas, Inc. revenue of about $6.83B for fiscal 2026, with EPS near $0.61. The estimate reflects 3 contributing analysts.

Over the past six months, Ventas, Inc. insiders filed 29 SEC Form 4 transactions — 1 sales and 28 purchases. On net that is roughly 40K shares acquired (about $3.6M) — insiders putting money in tends to read as conviction.

VTR Financials

VTR Latest News

VTR Analyst Consensus

VTR MoonshotScore

Latest Ventas, Inc. Analysis

Common Questions About VTR (Real Estate)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources